Stem Cell Potential: Lift the Funding Ban, and Allow NIH Oversight and Development of New Therapies
Butler, Robert N.
Geriatrics 2000 September; 55(9): 15
Showing items related by title, author, creator and subject.
Regulatory considerations for the development of autologous induced pluripotent stem cell therapies. Carpenter, Melissa K; Couture, Larry A (2010-07)Induced pluripotent stem (iPS) cells offer tremendous opportunity for the creation of autologous cellular therapies, in which gene correction or the avoidance of immune response issues are desirable. In addition, iPS cells ...